BREAKTHROUGHS IN PANCREATIC CANCER TREATMENT

Pancreatic cancer remains one of oncology's most difficult challenges - but the science behind it is changing faster than most patients, caregivers, and even clinicians realize.

Breakthroughs in Pancreatic Cancer Treatment is a clear, evidence-based guide to the molecular revolution now reshaping this disease. At its center is KRAS, the gene mutated in nearly 90% of pancreatic cancers, and the decades-long scientific effort to turn it from an "undruggable" target into a viable therapeutic one. This book explains how that effort succeeded, what it means for patients today, and where the research - including emerging agents like daraxonrasib - genuinely stands.

Written by Andrew J. Harmon, M.Sc., in a tone that favors precision over promotion, the book covers:

• The biology of the pancreas and why this cancer is so hard to catch early
• KRAS mutations and the science of precision oncology
• How chemotherapy, surgery, and immunotherapy fit into modern treatment
• Emerging KRAS-targeted therapies and what current clinical trial evidence actually shows
• How to read clinical trial data, biomarkers, and survival statistics with a critical eye
• Managing side effects, nutrition, pain, and emotional health during treatment
• Treatment resistance, combination strategies, and where research is headed next
• Nearly 40 patient FAQs, a 75+ term glossary, and a guide to reputable resources

This is not a promise of a cure, and it does not offer medical advice. It is a comprehensive, balanced reference - for patients making sense of a diagnosis, caregivers supporting a loved one, and clinicians, students, and science-minded readers who want an honest picture of where pancreatic cancer treatment is today, and where it's realistically going.